Blog: Nestle turns to Chinese medicine
Dean Best | 29 November 2012
In another sign the world's largest food maker is not just about Kit Kats, Nescafe or Maggi noodles, the Swiss food giant is now looking to use Chinese medicine in its fledgling health science business.
Nestle and pharma and healthcare group Chi-Med are going to team up and look into developing "nutritional and medicinal products" using botanical plants.
"This joint venture provides Nestlé Health Science with an opportunity to develop and commercialise truly innovative and scientifically validated botanical-based nutrition for personalised healthcare in gastrointestinal health," Luis Cantarell, president and CEO for Nestlé Health Science, said.
Hutchison MediPharma Limited, a subsidiary of Chi-Med, is already developing what Nestle called a "first-of-its-kind botanical product", to be taken orally, to manage moderate inflammatory bowel disease.
The venture may raise some eyebrows in the food industry but it is a sign Nestle is confident efforts to carve a third way between nutrition and pharmaceuticals will pay dividends in a world facing growing health challenges from non-communicable diseases and, in the developed world, ageing populations.
Since Theresa May took over as UK Prime Minister in the wake of the country's referendum vote to quit the European Union, she and her ministers have been at pains not to divulge their negotiating posi...
Greenpeace's long-running campaign against UK tuna brand John West, owned by seafood giant Thai Union, is now directing its fire against Sainsbury's....
The Obama administration appears to have conceded the landmark Trans-Pacific Partnership (TPP) trade deal will not be pushed through in the lame-duck session of Congress before Donald Trump is inaugur...
- Unilever 2016 investor day - the top takeaways
- Have food promotions reached tipping point?
- Mondelez goes beyond certified cocoa - analysis
- Quorn CEO sets out stall for 2017 - interview
- What Premier CEO Gavin Darby thinks about Brexit
- Nestle unveils process to cut sugar by 40%
- Putin 'wants embargo to run as long as possible'
- Unilever sets new margin target with help from ZBB
- Unilever focuses on "value" of spreads arm
- McCormick to buy flavours business Enrico Giotti